Agonist binding to G-protein coupled receptors

British Journal of Pharmacology

Volumn 129, Issue 4, 2000, Pages 820-821

  Strange, Philip G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Agonist binding; G protein coupled receptors; Receptor activation; Receptor theory

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; MUTANT PROTEIN; SODIUM ION;

AMINO ACID SUBSTITUTION; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; HUMAN; HYDROGEN BOND; LETTER; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0034116151     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702991     Document Type: Letter

References (16)

1. Ballasteros, J., Kitanovic, S., Guarnieri, F., Davies, P., Fromme, B.J., Konvicka, K., Chi, L., Millar, R.P., Davidson, J.S., Weinstein, H. & Sealfon, S.C. (1998). Functional microdomains in G-protein coupled receptors. J. Biol. Chem., 273, 10445-10453.
2. Chung, F., Wang, C., Potter, P.C., Venter, J.C. & Fraser, C.M. (1988). Site directed mutagenesis and continuous expression of the human β-adrenergic receptor. J. Biol. Chem., 263, 4052-4055.
3. Colquhoun, D. (1998). Binding, gating and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol., 125, 924-947.
4. Fraser, C.M., Wang, C., Robinson, D.A., Gocayne, J.D. & Venter, J.C. (1990). Site directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol., 36, 840-847.
5. Horstman, D.A., Brandon, S., Wilson, A.L., Guyer, C.A., Crago, E.J. & Limbird, L.E. (1990). An aspartate conserved among G-protein coupled receptors confers allosteric regulation of α2 adrenergic receptors by sodium ions. J. Biol. Chem., 265, 21590-21595.
6. Lefkowitz, R.J., Cotecchia, S., Samama, P. & Costa, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci., 14, 303-307.
7. Neve, K.A., Cox, B.A., Henningsen, R.A., Spanoyannis, A. & Neve, R.L. (1991). Pivotal role for aspartate 80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol., 39, 733-739.
8. 2-adrenergic receptor. J. Biol. Chem., 268, 4625-4636.
9. Strader, C.D., Sigal, I.S., Candelore, M.R., Rands, E., Hill, W.S. & Dixon, R.A.F. (1988). Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem., 263, 10267-10271.
10. Strader, C.D., Sigal, I.S., Register, R.B., Candelore, M.R., Rands, E. & Dixon, R.A.F. (1987). Identification of residues required for ligand binding to the β-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A., 84, 4384-4388.
11. Strange, P.G. (1996). The energetics of ligand binding at catecholamine receptors. Trends. Pharmacol. Sci., 17, 238-244.
12. Strange P.G. (1998) Three state and two state models. Trends. Pharmacol. Sci., 19, 85-86.
13. Strange, P.G. (1999). G-protein coupled receptors: conformations and states. Biochem. Pharmacol., 58, 1081-1088.
14. Van Rhee, A.M. & Jacobsen, K.A. (1996). Molecular architecture of G-protein coupled receptors. Drug Dev. Res., 37, 1-38.
15. 2A adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonist. Mol. Pharmacol., 40, 168-179.
16. Wang, C., Gallagher, T.K. & Shih, J.C. (1993). Site directed mutagenesis of the serotonin 5HT2 receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol., 43, 931-940.